Cytokinetics (CYTK) Misses Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $67.59 +0.04%
Revenue Growth %: +1,966.3%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
NEOV, MANU, CTAS, More
Revenue Growth %: +1,966.3%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($0.54), $0.07 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $6.86 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy
- AutoZone beats profit view but misses on revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
